Rubin Jonathan

CIK 00018360671 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001836067

Recent Transactions

50 trades

Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-25+1,250→ 14,016 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-25−1,250→ 1,250 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-25$50.69/sh−675→ 13,341 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−1,125→ 3,375 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24−671→ 12,766 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+1,250→ 13,437 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24$50.86/sh−369→ 12,187 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+750→ 12,556 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24+1,125→ 12,409 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-02-24$51.35/sh−603→ 11,806 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−1,250→ 2,500 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-24−750→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2026-02-18+3,000→ 3,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2026-02-18+13,500→ 13,500 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-09-25−1,875→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-25+1,875→ 11,855 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-09-25$46.21/sh−840→ 11,015 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2025-09-10+1,875→ 1,875 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−314→ 10,789 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−577→ 9,635 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-03-05$33.05/sh−577→ 10,212 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-23−1,250→ 2,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-23+1,250→ 11,103 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+1,250→ 9,853 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−750→ 750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+750→ 8,603 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-22−1,250→ 3,750 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-02-21−1,875→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21+1,875→ 8,780 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-21$39.15/sh−927→ 7,853 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,500→ 4,500 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2025-02-19+20,000→ 20,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Units
2025-01-28+1,875→ 1,875 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−750→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−281→ 5,541 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+1,875→ 7,416 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27+750→ 5,822 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-27−1,875→ 0 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-12-27$35.59/sh−821→ 6,595 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-23+750→ 750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Performance Share Unit
2024-12-23+1,875→ 1,875 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23$29.06/sh−567→ 4,641 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+1,250→ 5,208 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−1,250→ 3,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22+5,000→ 5,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22+750→ 4,261 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Employee Stock Option (Right to Buy)
2024-02-22+25,000→ 25,000 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-22−750→ 1,500 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-22$27.94/sh−303→ 3,958 total
Tax Payment
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-12-22$27.66/sh−204→ 3,243 total

Companies

SUPERNUS PHARMACEUTICALS, INC.
SVP, Chief Medical Officer
$SUPN

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov